This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN advanced 3.97% to $2.62 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.67% to 4,091.19 and Dow Jones Industrial Average DJIA falling 1.23% to 32,396.17. The stock's rise snapped a three-day losing streak. Ocugen Inc. closed $15.03 below its 52-week high ($17.65), which the company reached on November 3rd.
The stock outperformed some of its competitors Tuesday, as Adverum Biotechnologies Inc. ADVM fell 5.07% to $1.31, Ocular Therapeutix Inc. OCUL rose 3.03% to $4.42, and Kodiak Sciences Inc. KOD fell 12.98% to $8.31. Trading volume (4.1 M) remained 2.2 million below its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 2, 2022.
(END) Dow Jones Newswires
August 02, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.